ACS Medicinal Chemistry Letters · 2012 · 95 citations · 18 references
MedicineNeurosciencePharmacologyDrug DesignDrug DiscoveryNeuropharmacologyCholinergic NeurochemistryCholinergic PharmacologyEnzyme InhibitionNeurochemical PharmacologyNeuroprotectionNeuroprotective PharmacologyAcetylcholinesterase InhibitorsButyrylcholinesterase InhibitionChemical Structure-activity RelationshipsChemical Synthesis Of AnaloguesMedicinal Chemistry ApplicationsNeuroprotective AgentsNeuroprotective Drug DevelopmentNeuroprotective Mechanisms
Tri- and tetracyclic nitrogen-bridgehead compounds were designed and synthesized to yield micromolar cholinesterase (ChE) inhibitors. Structure-activity relationships identified potent compounds with butyrylcholinesterase selectivity. These compounds were selected as starting points for the design and synthesis of carbamate-based (pseudo)irreversible inhibitors. Compounds with superior inhibitory activity and selectivity were obtained and kinetically characterized also with regard to the velocity of enzyme carbamoylation. Structural elements were identified and introduced that additionally showed neuroprotective properties on a hippocampal neuronal cell line (HT-22) after glutamate-induced intracellular reactive oxygen species generation. We have identified potent and selective pseudoirreversible butyrylcholinesterase inhibitors that release reversible inhibitors with neuroprotective properties after carbamate transfer to the active site of cholinesterases.
18
Nigel H. Greig, Tadanobu Utsuki, Donald K. Ingram et al. · Proceedings of the National Academy of Sciences · 2005 · 723 citations · Full text